NR3C1 and serum lipopolysaccharide activity: Escin reduces hepatic inflammatory mediators, mitigates inflammatory responses, upregulates the expression of 11β-hydroxysteroid dehydrogenase 2 and glucocorticoid receptors, and enhances endogenous antioxidant capacity, thereby alleviating liver injury induced by endotoxemia [81].